Several approved drugs, such as copyright and Semaglutide, are part of the incretin mimetic class . Primarily , these therapies are designed to mimicking endogenous chemicals that regulate blood sugar https://dianedzbq800069.blogs-service.com/72226006/copyright-and-glp-1-receptor-agonists-understanding-the-drugs